Industry Research Reports
Global Automatic Breast Ultrasound Diagnosis Systems Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 171 Pages
Report ld: 5344223
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Automatic Breast Ultrasound Diagnosis Systems Market Size(US$)
CAGR 2025-2031
8.7%
Market Size,2031
USD 3,814
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Automatic Breast Ultrasound Diagnosis Systems market is projected to grow from US$ 2144 million in 2024 to US$ 3814 million by 2031, at a CAGR of 8.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Automated breast ultrasound diagnostic systems are used as an adjunct to mammography to screen for breast cancer in asymptomatic women with dense breasts. It is an effective screening modality that can differentiate between cysts, fibroadenomas, cancer or infection. The size of the lesion can be measured, the exact location is easily determined, or it can be precisely positioned for surgical procedures.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. The automated breast volume scanner (ABVS) segment is expected to hold the largest share during the forecast period, ABVS uses a scanner to precisely examine lactiferous ducts and evaluate breast volume images by high frequency ultrasound. The non-radioactivity, efficiency, repeatability and 3D reconstruction offered by this ultrasound system are just a few of its many advantages. Demand will rise as patient preference for minimally invasive diagnostic procedures increases. Real-time imaging support enables the chain of command. Other benefits of ABVS include faster, less painful surgery and improved diagnostic accuracy, leading to earlier breast cancer diagnosis. The results of this technique can be used for insightful preoperative surgical planning. The hospital segment accounted for the highest share in 2020 and is expected to maintain this trend over the forecast period owing to increasing patient population, faster availability of medical instruments and equipment, and presence of skilled personnel. The use of ABUS in hospitals is receiving increasing attention as a means of meeting the diagnostic needs of patients. Increased awareness of regular cancer screening tests among young and middle-aged women will drive demand for ABUS and ABVS in these healthcare facilities as pregnant women are unable to undergo mammograms due to radiation risks and hospitals are installing ABUS to provide a safer diagnostic option .
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Automatic Breast Ultrasound Diagnosis Systems market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- GE Healthcare
- Siemens
- Hitachi
- SonoCiné
- Koninklijke Philips
- QView Medical
- Seno Medical Instruments
- Volpara Solutions
- Delphinus Medical Technologies
- CapeRay
- SuperSonic Imagine
- Nova Medical Imaging Technology
- SIUI
- Theraclion
- Real Imaging
- MetriTrack
- Toshiba
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Automated Breast Ultrasound Systems
- Automated Breast Volume Scanner
Segment by Application
- Hospitals
- Diagnostic Imaging Laboratories
CHAPTER OUTLINE
Chapter 1: Defines the Automatic Breast Ultrasound Diagnosis Systems study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Automatic Breast Ultrasound Diagnosis Systems: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Automatic Breast Ultrasound Diagnosis Systems Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Automated Breast Ultrasound Systems
1.2.3 Automated Breast Volume Scanner
1.3 Market Segmentation by Application
1.3.1 Global Automatic Breast Ultrasound Diagnosis Systems Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Diagnostic Imaging Laboratories
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Automatic Breast Ultrasound Diagnosis Systems Revenue Estimates and Forecasts 2020-2031
2.2 Global Automatic Breast Ultrasound Diagnosis Systems Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Automatic Breast Ultrasound Diagnosis Systems Sales Estimates and Forecasts 2020-2031
2.4 Global Automatic Breast Ultrasound Diagnosis Systems Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Automatic Breast Ultrasound Diagnosis Systems Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Automatic Breast Ultrasound Diagnosis Systems Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Automated Breast Ultrasound Systems Market Size by Manufacturers
3.5.2 Automated Breast Volume Scanner Market Size by Manufacturers
3.6 Global Automatic Breast Ultrasound Diagnosis Systems Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Automatic Breast Ultrasound Diagnosis Systems Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Automatic Breast Ultrasound Diagnosis Systems Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Automatic Breast Ultrasound Diagnosis Systems Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Automatic Breast Ultrasound Diagnosis Systems Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Automatic Breast Ultrasound Diagnosis Systems Sales and Revenue by Type (2020-2031)
6.4 North America Automatic Breast Ultrasound Diagnosis Systems Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Automatic Breast Ultrasound Diagnosis Systems Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Automatic Breast Ultrasound Diagnosis Systems Sales and Revenue by Type (2020-2031)
7.4 Europe Automatic Breast Ultrasound Diagnosis Systems Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Automatic Breast Ultrasound Diagnosis Systems Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Automatic Breast Ultrasound Diagnosis Systems Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Automatic Breast Ultrasound Diagnosis Systems Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Automatic Breast Ultrasound Diagnosis Systems Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Automatic Breast Ultrasound Diagnosis Systems Sales and Revenue by Type (2020-2031)
9.4 Central and South America Automatic Breast Ultrasound Diagnosis Systems Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Automatic Breast Ultrasound Diagnosis Systems Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Automatic Breast Ultrasound Diagnosis Systems Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Automatic Breast Ultrasound Diagnosis Systems Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Automatic Breast Ultrasound Diagnosis Systems Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 GE Healthcare
11.1.1 GE Healthcare Corporation Information
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare Automatic Breast Ultrasound Diagnosis Systems Product Models, Descriptions and Specifications
11.1.4 GE Healthcare Automatic Breast Ultrasound Diagnosis Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 GE Healthcare Automatic Breast Ultrasound Diagnosis Systems Sales by Product in 2024
11.1.6 GE Healthcare Automatic Breast Ultrasound Diagnosis Systems Sales by Application in 2024
11.1.7 GE Healthcare Automatic Breast Ultrasound Diagnosis Systems Sales by Geographic Area in 2024
11.1.8 GE Healthcare Automatic Breast Ultrasound Diagnosis Systems SWOT Analysis
11.1.9 GE Healthcare Recent Developments
11.2 Siemens
11.2.1 Siemens Corporation Information
11.2.2 Siemens Business Overview
11.2.3 Siemens Automatic Breast Ultrasound Diagnosis Systems Product Models, Descriptions and Specifications
11.2.4 Siemens Automatic Breast Ultrasound Diagnosis Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Siemens Automatic Breast Ultrasound Diagnosis Systems Sales by Product in 2024
11.2.6 Siemens Automatic Breast Ultrasound Diagnosis Systems Sales by Application in 2024
11.2.7 Siemens Automatic Breast Ultrasound Diagnosis Systems Sales by Geographic Area in 2024
11.2.8 Siemens Automatic Breast Ultrasound Diagnosis Systems SWOT Analysis
11.2.9 Siemens Recent Developments
11.3 Hitachi
11.3.1 Hitachi Corporation Information
11.3.2 Hitachi Business Overview
11.3.3 Hitachi Automatic Breast Ultrasound Diagnosis Systems Product Models, Descriptions and Specifications
11.3.4 Hitachi Automatic Breast Ultrasound Diagnosis Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Hitachi Automatic Breast Ultrasound Diagnosis Systems Sales by Product in 2024
11.3.6 Hitachi Automatic Breast Ultrasound Diagnosis Systems Sales by Application in 2024
11.3.7 Hitachi Automatic Breast Ultrasound Diagnosis Systems Sales by Geographic Area in 2024
11.3.8 Hitachi Automatic Breast Ultrasound Diagnosis Systems SWOT Analysis
11.3.9 Hitachi Recent Developments
11.4 SonoCiné
11.4.1 SonoCiné Corporation Information
11.4.2 SonoCiné Business Overview
11.4.3 SonoCiné Automatic Breast Ultrasound Diagnosis Systems Product Models, Descriptions and Specifications
11.4.4 SonoCiné Automatic Breast Ultrasound Diagnosis Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 SonoCiné Automatic Breast Ultrasound Diagnosis Systems Sales by Product in 2024
11.4.6 SonoCiné Automatic Breast Ultrasound Diagnosis Systems Sales by Application in 2024
11.4.7 SonoCiné Automatic Breast Ultrasound Diagnosis Systems Sales by Geographic Area in 2024
11.4.8 SonoCiné Automatic Breast Ultrasound Diagnosis Systems SWOT Analysis
11.4.9 SonoCiné Recent Developments
11.5 Koninklijke Philips
11.5.1 Koninklijke Philips Corporation Information
11.5.2 Koninklijke Philips Business Overview
11.5.3 Koninklijke Philips Automatic Breast Ultrasound Diagnosis Systems Product Models, Descriptions and Specifications
11.5.4 Koninklijke Philips Automatic Breast Ultrasound Diagnosis Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Koninklijke Philips Automatic Breast Ultrasound Diagnosis Systems Sales by Product in 2024
11.5.6 Koninklijke Philips Automatic Breast Ultrasound Diagnosis Systems Sales by Application in 2024
11.5.7 Koninklijke Philips Automatic Breast Ultrasound Diagnosis Systems Sales by Geographic Area in 2024
11.5.8 Koninklijke Philips Automatic Breast Ultrasound Diagnosis Systems SWOT Analysis
11.5.9 Koninklijke Philips Recent Developments
11.6 QView Medical
11.6.1 QView Medical Corporation Information
11.6.2 QView Medical Business Overview
11.6.3 QView Medical Automatic Breast Ultrasound Diagnosis Systems Product Models, Descriptions and Specifications
11.6.4 QView Medical Automatic Breast Ultrasound Diagnosis Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 QView Medical Recent Developments
11.7 Seno Medical Instruments
11.7.1 Seno Medical Instruments Corporation Information
11.7.2 Seno Medical Instruments Business Overview
11.7.3 Seno Medical Instruments Automatic Breast Ultrasound Diagnosis Systems Product Models, Descriptions and Specifications
11.7.4 Seno Medical Instruments Automatic Breast Ultrasound Diagnosis Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Seno Medical Instruments Recent Developments
11.8 Volpara Solutions
11.8.1 Volpara Solutions Corporation Information
11.8.2 Volpara Solutions Business Overview
11.8.3 Volpara Solutions Automatic Breast Ultrasound Diagnosis Systems Product Models, Descriptions and Specifications
11.8.4 Volpara Solutions Automatic Breast Ultrasound Diagnosis Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Volpara Solutions Recent Developments
11.9 Delphinus Medical Technologies
11.9.1 Delphinus Medical Technologies Corporation Information
11.9.2 Delphinus Medical Technologies Business Overview
11.9.3 Delphinus Medical Technologies Automatic Breast Ultrasound Diagnosis Systems Product Models, Descriptions and Specifications
11.9.4 Delphinus Medical Technologies Automatic Breast Ultrasound Diagnosis Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Delphinus Medical Technologies Recent Developments
11.10 CapeRay
11.10.1 CapeRay Corporation Information
11.10.2 CapeRay Business Overview
11.10.3 CapeRay Automatic Breast Ultrasound Diagnosis Systems Product Models, Descriptions and Specifications
11.10.4 CapeRay Automatic Breast Ultrasound Diagnosis Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 CapeRay Recent Developments
11.11 SuperSonic Imagine
11.11.1 SuperSonic Imagine Corporation Information
11.11.2 SuperSonic Imagine Business Overview
11.11.3 SuperSonic Imagine Automatic Breast Ultrasound Diagnosis Systems Product Models, Descriptions and Specifications
11.11.4 SuperSonic Imagine Automatic Breast Ultrasound Diagnosis Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 SuperSonic Imagine Recent Developments
11.12 Nova Medical Imaging Technology
11.12.1 Nova Medical Imaging Technology Corporation Information
11.12.2 Nova Medical Imaging Technology Business Overview
11.12.3 Nova Medical Imaging Technology Automatic Breast Ultrasound Diagnosis Systems Product Models, Descriptions and Specifications
11.12.4 Nova Medical Imaging Technology Automatic Breast Ultrasound Diagnosis Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Nova Medical Imaging Technology Recent Developments
11.13 SIUI
11.13.1 SIUI Corporation Information
11.13.2 SIUI Business Overview
11.13.3 SIUI Automatic Breast Ultrasound Diagnosis Systems Product Models, Descriptions and Specifications
11.13.4 SIUI Automatic Breast Ultrasound Diagnosis Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 SIUI Recent Developments
11.14 Theraclion
11.14.1 Theraclion Corporation Information
11.14.2 Theraclion Business Overview
11.14.3 Theraclion Automatic Breast Ultrasound Diagnosis Systems Product Models, Descriptions and Specifications
11.14.4 Theraclion Automatic Breast Ultrasound Diagnosis Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Theraclion Recent Developments
11.15 Real Imaging
11.15.1 Real Imaging Corporation Information
11.15.2 Real Imaging Business Overview
11.15.3 Real Imaging Automatic Breast Ultrasound Diagnosis Systems Product Models, Descriptions and Specifications
11.15.4 Real Imaging Automatic Breast Ultrasound Diagnosis Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Real Imaging Recent Developments
11.16 MetriTrack
11.16.1 MetriTrack Corporation Information
11.16.2 MetriTrack Business Overview
11.16.3 MetriTrack Automatic Breast Ultrasound Diagnosis Systems Product Models, Descriptions and Specifications
11.16.4 MetriTrack Automatic Breast Ultrasound Diagnosis Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 MetriTrack Recent Developments
11.17 Toshiba
11.17.1 Toshiba Corporation Information
11.17.2 Toshiba Business Overview
11.17.3 Toshiba Automatic Breast Ultrasound Diagnosis Systems Product Models, Descriptions and Specifications
11.17.4 Toshiba Automatic Breast Ultrasound Diagnosis Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Toshiba Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Automatic Breast Ultrasound Diagnosis Systems Industry Chain
12.2 Automatic Breast Ultrasound Diagnosis Systems Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Automatic Breast Ultrasound Diagnosis Systems Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Automatic Breast Ultrasound Diagnosis Systems Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Automatic Breast Ultrasound Diagnosis Systems Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Automatic Breast Ultrasound Diagnosis Systems Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
Automatic Breast Ultrasound Diagnosis Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Automatic Breast Ultrasound Diagnosis Systems was estimated to be worth US$ 2312 million in 2025 and is projected to reach US$ 4113 million, growing at a CAGR of 8.7% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 149
USD 3950.00
(Single User License)
Global Automatic Breast Ultrasound Diagnosis Systems Market Research Report 2026
The global Automatic Breast Ultrasound Diagnosis Systems market was valued at US$ 2312 million in 2025 and is anticipated to reach US$ 4113 million by 2032, at a CAGR of 8.7% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 129
USD 2900.00
(Single User License)
Global Automatic Breast Ultrasound Diagnosis Systems Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Automatic Breast Ultrasound Diagnosis Systems market size was US$ 2144 million in 2024 and is forecast to a readjusted size of US$ 3814 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 104
USD 4250.00
(Single User License)
Global Automatic Breast Ultrasound Diagnosis Systems Market Research Report 2025
The global market for Automatic Breast Ultrasound Diagnosis Systems was valued at US$ 2144 million in the year 2024 and is projected to reach a revised size of US$ 3814 million by 2031, growing at a CAGR of 8.7% during the forecast period.
Published Date: 2025-01-16
Pages: 99
USD 2900.00
(Single User License)
Automatic Breast Ultrasound Diagnosis Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Automatic Breast Ultrasound Diagnosis Systems was estimated to be worth US$ 2144 million in 2024 and is forecast to a readjusted size of US$ 3814 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 139
USD 3950.00
(Single User License)
Global Automatic Breast Ultrasound Diagnosis Systems Market Research Report 2024
Automated breast ultrasound diagnostic systems are used as an adjunct to mammography to screen for breast cancer in asymptomatic women with dense breasts. It is an effective screening modality that can differentiate between cysts, fibroadenomas, cancer or infection. The size of the lesion can be measured, the exact location is easily determined, or it can be precisely positioned for surgical procedures.
Published Date: 2024-01-20
Pages: 101
USD 2900.00
(Single User License)
Automatic Breast Ultrasound Diagnosis Systems - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Automated breast ultrasound diagnostic systems are used as an adjunct to mammography to screen for breast cancer in asymptomatic women with dense breasts. It is an effective screening modality that can differentiate between cysts, fibroadenomas, cancer or infection. The size of the lesion can be measured, the exact location is easily determined, or it can be precisely positioned for surgical procedures.
Published Date: 2024-01-11
Pages: 141
USD 3950.00
(Single User License)
Automatic Breast Ultrasound Diagnosis Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Automatic Breast Ultrasound Diagnosis Systems was estimated to be worth US$ 2312 million in 2025 and is projected to reach US$ 4113 million, growing at a CAGR of 8.7% from 2026 to 2032.
Published: 2026-06-16
Pages: 149
USD 3950.00 (Single User License)Global Automatic Breast Ultrasound Diagnosis Systems Market Research Report 2026
The global Automatic Breast Ultrasound Diagnosis Systems market was valued at US$ 2312 million in 2025 and is anticipated to reach US$ 4113 million by 2032, at a CAGR of 8.7% from 2026 to 2032.
Published: 2026-04-17
Pages: 129
USD 2900.00 (Single User License)Global Automatic Breast Ultrasound Diagnosis Systems Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Automatic Breast Ultrasound Diagnosis Systems market size was US$ 2144 million in 2024 and is forecast to a readjusted size of US$ 3814 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 104
USD 4250.00 (Single User License)Global Automatic Breast Ultrasound Diagnosis Systems Market Research Report 2025
The global market for Automatic Breast Ultrasound Diagnosis Systems was valued at US$ 2144 million in the year 2024 and is projected to reach a revised size of US$ 3814 million by 2031, growing at a CAGR of 8.7% during the forecast period.
Published: 2025-01-16
Pages: 99
USD 2900.00 (Single User License)Automatic Breast Ultrasound Diagnosis Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Automatic Breast Ultrasound Diagnosis Systems was estimated to be worth US$ 2144 million in 2024 and is forecast to a readjusted size of US$ 3814 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 139
USD 3950.00 (Single User License)Global Automatic Breast Ultrasound Diagnosis Systems Market Research Report 2024
Automated breast ultrasound diagnostic systems are used as an adjunct to mammography to screen for breast cancer in asymptomatic women with dense breasts. It is an effective screening modality that can differentiate between cysts, fibroadenomas, cancer or infection. The size of the lesion can be measured, the exact location is easily determined, or it can be precisely positioned for surgical procedures.
Published: 2024-01-20
Pages: 101
USD 2900.00 (Single User License)Automatic Breast Ultrasound Diagnosis Systems - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Automated breast ultrasound diagnostic systems are used as an adjunct to mammography to screen for breast cancer in asymptomatic women with dense breasts. It is an effective screening modality that can differentiate between cysts, fibroadenomas, cancer or infection. The size of the lesion can be measured, the exact location is easily determined, or it can be precisely positioned for surgical procedures.
Published: 2024-01-11
Pages: 141
USD 3950.00 (Single User License)
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now